CN105232990A - Traditional Chinese medicine for treating BPH combined overactive bladder syndrome - Google Patents
Traditional Chinese medicine for treating BPH combined overactive bladder syndrome Download PDFInfo
- Publication number
- CN105232990A CN105232990A CN201510773736.7A CN201510773736A CN105232990A CN 105232990 A CN105232990 A CN 105232990A CN 201510773736 A CN201510773736 A CN 201510773736A CN 105232990 A CN105232990 A CN 105232990A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- overactive bladder
- treatment
- bph
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 45
- 206010020853 Hypertonic bladder Diseases 0.000 title claims abstract description 24
- 208000009722 Overactive Urinary Bladder Diseases 0.000 title claims abstract description 24
- 208000020629 overactive bladder Diseases 0.000 title claims abstract description 23
- 208000011580 syndromic disease Diseases 0.000 title abstract description 6
- 241000024149 Herminium monorchis Species 0.000 claims abstract description 15
- 241000592274 Polypodium vulgare Species 0.000 claims abstract description 15
- 238000011282 treatment Methods 0.000 claims description 45
- 239000009526 Fructus Akebiae Substances 0.000 claims description 15
- 210000000582 semen Anatomy 0.000 claims description 14
- 241000208340 Araliaceae Species 0.000 claims description 13
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 13
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 13
- 241000001482 Pedicularis davidii Species 0.000 claims description 13
- 235000008434 ginseng Nutrition 0.000 claims description 13
- 239000011435 rock Substances 0.000 claims description 13
- 210000003734 kidney Anatomy 0.000 abstract description 27
- 210000000952 spleen Anatomy 0.000 abstract description 14
- 229940079593 drug Drugs 0.000 abstract description 9
- 235000013399 edible fruits Nutrition 0.000 abstract description 7
- 241001517299 Bulbophyllum Species 0.000 abstract description 2
- 244000303286 Stachys officinalis Species 0.000 abstract description 2
- 235000009225 Stachys officinalis Nutrition 0.000 abstract description 2
- 235000018907 Tylosema fassoglense Nutrition 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 241000722953 Akebia Species 0.000 abstract 1
- 241001508399 Elaeagnus Species 0.000 abstract 1
- 241000933771 Ficus erecta Species 0.000 abstract 1
- 241001071795 Gentiana Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 235000002384 Malva verticillata Nutrition 0.000 abstract 1
- 240000003065 Malva verticillata Species 0.000 abstract 1
- 241000330755 Tylosema fassoglense Species 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 210000003932 urinary bladder Anatomy 0.000 description 21
- 230000007812 deficiency Effects 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 9
- 208000004880 Polyuria Diseases 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 6
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 6
- 230000027939 micturition Effects 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 5
- 230000008506 pathogenesis Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 244000241257 Cucumis melo Species 0.000 description 4
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 4
- 241000167859 Pedicularis Species 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000002307 prostate Anatomy 0.000 description 4
- 230000001047 pyretic effect Effects 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000345998 Calamus manan Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 102000007066 Prostate-Specific Antigen Human genes 0.000 description 3
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 206010046555 Urinary retention Diseases 0.000 description 3
- 206010046814 Uterine prolapse Diseases 0.000 description 3
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 235000012950 rattan cane Nutrition 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 206010071445 Bladder outlet obstruction Diseases 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 244000249585 Elaeagnus conferta Species 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 208000003800 Urinary Bladder Neck Obstruction Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- 241001571504 Aspidopterys obcordata Species 0.000 description 1
- 241000220487 Bauhinia Species 0.000 description 1
- 240000003521 Bauhinia purpurea Species 0.000 description 1
- 235000011462 Bauhinia purpurea Nutrition 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 235000016535 Capraria biflora Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 241000967320 Gentianella quinquefolia Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 240000006760 Holboellia latifolia Species 0.000 description 1
- 235000014565 Holboellia latifolia Nutrition 0.000 description 1
- 235000002336 Holboellia parviflora Nutrition 0.000 description 1
- 241000340664 Holboellia parviflora Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 241001083838 Lardizabalaceae Species 0.000 description 1
- 241001582888 Lobus Species 0.000 description 1
- 206010071289 Lower urinary tract symptoms Diseases 0.000 description 1
- 241000208949 Malpighiaceae Species 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000000693 Neurogenic Urinary Bladder Diseases 0.000 description 1
- 206010029279 Neurogenic bladder Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010065584 Urethral stenosis Diseases 0.000 description 1
- 208000000921 Urge Urinary Incontinence Diseases 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 208000012931 Urologic disease Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229960001389 doxazosin Drugs 0.000 description 1
- RUZYUOTYCVRMRZ-UHFFFAOYSA-N doxazosin Chemical compound C1OC2=CC=CC=C2OC1C(=O)N(CC1)CCN1C1=NC(N)=C(C=C(C(OC)=C2)OC)C2=N1 RUZYUOTYCVRMRZ-UHFFFAOYSA-N 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 238000010832 independent-sample T-test Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 239000003087 receptor blocking agent Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 235000020254 sheep milk Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 201000001988 urethral stricture Diseases 0.000 description 1
- 206010046494 urge incontinence Diseases 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000003202 urodynamic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of medicine, and particularly relates to traditional Chinese medicine for treating a BPH combined overactive bladder syndrome. The traditional Chinese medicine is prepared from, by weight, 4-8 parts of gentiana sarcorrhiza ling et ma, 4-8 parts of ficus erecta roots, 4-8 parts of leaf of manynerve bauhinia, 4-8 parts of cluster mallow, 4-8 parts of rhizome of david woodbetony, 4-8 parts of herminium monorchis, 4-8 parts of fruits of fiverleaf akebia, 4-8 parts of leaves of delavey greenleaf elaeagnus, 4-8 parts of bigbract bulbophyllum, 4-8 parts of stems of obheartleaf, 4-8 parts of polypodium vulgare and 4-8 parts of tips of licorice roots. The medicines are combined, and the effects of invigorating the spleen, supplementing Qi, enriching Yin, nourishing the kidney and eliminating dampness and heat are achieved.
Description
Technical field
The invention belongs to medical art, be specifically related to a kind of Chinese medicine for the treatment of BPH and merging overactive bladder.
Background technology
The syndrome of overactive bladder to be a kind of with symptoms of urgency be feature, often with frequent micturition and nocturia, can to accompany or without urge incontinence; Urodynamics can show as overactive detrusor, also can be other forms of urethra-bladder function barrier.
Benign prostate hyperplasia (benignprostatichyperplasia, BPH) is one of modal urologic disease of male being greater than 40 years old the age, and its pathologic prostatic hyperplasia incidence rate of male that the age is greater than 80 years old reaches more than 90%.Its most basic pathological change is bladder outlet obstruction (BOO) and detrusor of bladder changing function.Wherein, the detrusor instability (di) (detrttsorinstability, DI) being secondary to BPH can cause the overactive bladders (overactivebladder, OAB) such as BPH frequent micturition, urgent micturition.The lower urinary tract symptom (1owerurinarytractsymptoms, LUTs) being secondary to BPH has a strong impact on patients ' life quality.Current BPH merges Drug therapy mainly conbined usage m receptor and the α receptor blocking agent of OAB, and its effective percentage is about 80%.But it is more to there is untoward reaction, the shortcoming such as to recur after drug withdrawal, if the adverse reaction rates such as xerostomia are more than 20%.
Summary of the invention
Technical problem to be solved by this invention avoids the weak point existing for above-mentioned prior art, provides a kind of Chinese medicine for the treatment of BPH and merging overactive bladder.
The present invention is achieved through the following technical solutions:
Treat the Chinese medicine that BPH merges overactive bladder, be made up of the Chinese medicine of following weight portion:
Money ginseng 4-8 part, Radix Fici beecheyanae 4-8 part, Folium Bauhiniae pernervosae 4-8 part, Semen Abutili 4-8 part, Rhizoma Pedicularis Davidii 4-8 part, musk orchid 4-8 part, Fructus Akebiae 4-8 part, Folium Elaeagni delavayi 4-8 part, solely leaf rock pearl 4-8 part, Caulis Aspidopterydis obcordatae 4-8 part, adder's-fern 4-8 part, Radix Glycyrrhizae uralensis 4-8 part.
Preferably, above-mentioned treatment BPH merges the Chinese medicine of overactive bladder, is made up of the Chinese medicine of following weight portion:
Money ginseng 5-7 part, Radix Fici beecheyanae 5-7 part, Folium Bauhiniae pernervosae 5-7 part, Semen Abutili 5-7 part, Rhizoma Pedicularis Davidii 5-7 part, musk orchid 5-7 part, Fructus Akebiae 5-7 part, Folium Elaeagni delavayi 5-7 part, solely leaf rock pearl 5-7 part, Caulis Aspidopterydis obcordatae 5-7 part, adder's-fern 5-7 part, Radix Glycyrrhizae uralensis 5-7 part.
Preferred, above-mentioned treatment BPH merges the Chinese medicine of overactive bladder, is made up of the Chinese medicine of following weight portion:
Money join 6 parts, Radix Fici beecheyanae 6 parts, Folium Bauhiniae pernervosae 6 parts, Semen Abutili 6 parts, Rhizoma Pedicularis Davidii 6 parts, musk orchid 6 parts, Fructus Akebiae 6 parts, Folium Elaeagni delavayi 6 parts, solely 6 parts, leaf rock pearl, Caulis Aspidopterydis obcordatae 6 parts, adder's-fern 6 parts, Radix Glycyrrhizae uralensis 6 parts.
The ratio of above weight proportion is through that science screening obtains, and for especial patient, as serious symptom or mild, fat or modest patient, can the proportioning of amount of corresponding adjustment composition, and increase or reduce being no more than 100%, drug effect is substantially constant.
The weight portion of said medicine, if in units of g, the normally consumption of 1 dose.
The indication of Chinese medicine of the present invention: be used for the treatment of BPH and merge overactive bladder.
The taboo item of Chinese medicine of the present invention: the fasting for the treatment of period in a medicine is greasy, raw and cold, the smelling of fish or mutton, irritant and stodgy food.
In Chinese medicine of the present invention,
Money ginseng another name Radix Gentianae sarcorrhizae, little Radix Gentianae sarcorrhizae, a ginseng, derive from Gentianaceae agueweed money ginseng GentianasarcorrhizaLingetMa, be used as medicine with herb or root.Sweet in the mouth, warm in nature.Function invigorating the spleen and benefiting QI, tonifying the kidney to consolidate the essence.For body is empty after being ill, infantile malnutrition, cough due to deficiency of the lung, seminal emission, the enuresis, deficiency-heat is not moved back, children's's chronic diarrhea.
Radix Fici beecheyanae another name hair Fructus Fici Beecheyanae root is moraceae plants Fructus Fici Beecheyanae FicuserectaThumb.var.beecheyana(Hook.etArn.) root of King [F.beecheyanaHook.etArn.].Sweet in the mouth; Pungent; Warm in nature.Return lung; Spleen; Kidney channel.Function replenishing QI to invigorate the spleen; Promoting blood circulation to remove obstruction in the collateral; Expelling wind and removing dampness.Main overstrain is weak; Lack of appetite; Agalactia; Insufficiency of the spleen leucorrhea; Proctoptosis; Menoxenia; Wind syndrome of head pain; Traumatic injury; Rheumatic arthralgia.
Folium Bauhiniae pernervosae another name Radix Rumicis Japonici wind, Ren sus domestica rattan, be pulse family bauhinia many arteries and veins Bauhinia purpurea BauhiniapernervosaL.Chen, be used as medicine with root and leaf.Sweet in the mouth, acid, micro-hardship, warm in nature.Function tonifying the kidney to consolidate the essence, cough-relieving, hemostasis.Root: seminal emission, the enuresis, cough, metrorrhagia.Leaf: proctoptosis, uterine prolapse.
Semen Abutili another name Folium Malvae, sliding dish, Herba Fici Simplicissimae, Herba Capsellae cake leaf, for Malvaceae plant Semen Abutili MalvaverticillataL. is used as medicine with root, stem, Ye Jizi (Fructus Malvae).Stem, leaf: sweet, cold.Root: sweet, temperature.Function stem, leaf: clearing away heat-damp and promoting diuresis; For icterohepatitis.Root: invigorating the spleen and replenishing QI; Weak for the deficiency of vital energy, soreness of the waist and knees, the empty spontaneous perspiration of body, proctoptosis, uterine prolapse, chronic nephritis, diabetes.
Rhizoma Pedicularis Davidii another name david woodbetony rhizome, black Radix Panacis Quinquefolii.For the rhizome of goatweed David Radix seu Herba Pedicularis, rough Radix seu Herba Pedicularis, Deng Shi Radix seu Herba Pedicularis, Radix seu Herba Pedicularis attractive in appearance etc.Sweet micro-hardship, temperature.Enriching yin and nourishing kidney, invigorating the spleen and replenishing QI, invigorating the spleen and regulating the stomach.Control physical weakness, osteopyrexia and fever of suffering from a deficiency of the kidney, arthralgia, anorexia.
Musk orchid another name Rhizoma Tupistrae Chinensis, Herba Herminii, derive from the orchid family Herminium plant musk orchid Herminiummonorchis(L.) R.Brown., is used as medicine with whole herb with root.Nature and flavor are sweet, temperature.Function enriching yin and nourishing kidney, nourishing the stomach, regulating menstruation.For neurasthenia, dizzy insomnia, irritated thirsty inappetence, early whitening of beard and hair, menoxenia.
Fructus Akebiae another name cattle kidney fruit, June melon, little eight melons, any melon, Testis et Pentis Canis, wooden Fructus Trichosanthis Cucumeroidis, August fruit, savage's melon, Ramulus seu Fructus Caesalpiniae fruit, the lazy bag of cattle really.For the fruit of plants of Lardizabalaceae tendencies rattan HolboelliafargesiiReaub., wide leaf Fructus Akebiae HolboellialatifoliaWall. and little Hua Fructus Akebiae Holboelliaparviflora (Hemsl.) Gagnep..Bitter in the mouth; Cool in nature.Return bladder; The heart; Liver Channel.Function clearing away heat-damp and promoting diuresis; Blood circulation and channel invigorating; Promoting the circulation of QI to relieve pain.Main oliguria with reddish urine; Stranguria with turbid discharge; Edema; Rheumatic arthralgia; Traumatic injury; Galactostasis; Colicky; Uterine prolapse; Orchitis.
Folium Elaeagni delavayi another name elaeagnus conferta fruits, Yang Leishu, Radix Rubi Parvifolii, sheep milk milk, little elaeagnus conferta fruits.For leaf and the root bark of Elaeangnaceae plant Folium Elaeagni delavayi ElaeagnusviridisServ.var.delavayiLecte..Sweet in the mouth; Acid; Light; Property is put down.Return lung; Kidney; Urinary bladder channel.Function clearing away heat-damp and promoting diuresis; Tonglin Paishi; Relieving cough and asthma.Main chronic nephritis; Renal calculus; Urinary tract infection; Icterohepatitis; Chronic bronchitis; Bronchial asthma; Stomachache.
Only leaf rock pearl another name Herba Bulbophylli radiati, Moghania fluminalis(C. B. Clarke) Li, Herba sagittariae pygmaeae are blue, are the herb of orchid tooth lobe Bulbophyllum BulbopyllumpsychoonReichb.f. [B.levineiSchltr.].Sweet in the mouth; Light; Cold in nature.Function nourishing YIN and clearing away heat; Removing toxic substances and promoting subsidence of swelling.Main yin asthenia generating intrinsic heat; Calentura is thirsty; Lung-heat cough with asthma; Laryngopharynx swelling and pain; Stomatitis; Rheumatic arthralgia; Traumatic injury; Acute mastitis; Furuncle swells.
Caulis Aspidopterydis obcordatae another name is shouted lid and is passed through, and is the rattan of the Malpighiaceae plant Caulis Aspidopterydis obcordatae of falling lobus cardiacus AspidopterysobcordataHemsl..Lightly seasoned; Puckery; Cold nature.Return urinary bladder channel.Function clearing away heat and promoting diuresis; Dispelling wind and removing obstruction in the collateral.Main pyretic stranguria; Stranguria caused by urinary stone; Beriberoid pyretic arthralgia.
Adder's-fern is the rhizome of Plants of Polypodiaceae adder's-fern PolypodiumvulgareL. and Rhizoma Polygoni vivipari PolypodiumvirginianumL. ［ P.vulgareL.var.virginianumA.Eaton ］.Bitter in the mouth; Sweet; Cold nature.Function clearing away heat-damp and promoting diuresis detoxifies.Main damp and hot stranguria; Beriberoid pyretic arthralgia; Furuncle carbuncle; Rubella pruritus; Traumatic injury.
Radix Glycyrrhizae uralensis is that the last ending of glycyrrhizic legume GlycyrrhizauralensisFisch. root is divided or radicula.Sweet in the mouth; Cold in nature.GUIXIN, liver, spleen channel.Function eliminating fire and detoxication; Inducing diuresis for treating stranguria syndrome.Main pyretic stranguria; Oliguria; Pain in penis; Accumulated heat in the heart.
Overactive bladder is equivalent to the category of the traditional Chinese medical science " stranguria ".The stranguria origin cause of formation has inside and outside dividing, and its basic pathogenesis is that damp-heat in lower-JIAO pents up, and disturbance in functioning of QI, sick position is at kidney and bladder.The kidney dominating water metabolism, the urinary bladder being the viscus likened to a pond, both common main channel, conditioning aqueous vapor all over the body.When damp-heat accumulation bladder, or prolonged illness causes visceral dysfunction, then kidney and functioning of bladder unfavorable and cause stranguria.Propose in " General Treatise on the Cause and Symptoms of Diseases " " Zhu Linzhe, by suffer from a deficiency of the kidney bladder heat thus also ", " then frequent micturition of suffering from a deficiency of the kidney, bladder heat is then excessive under water, several and excessive, drenches drop and does not declare ".Later age doctor using this by kidney asthenia as the principal aspect, bladder heat for mark is as the pathogenesis basis of diagnosis and treatment stranguria, no matter deficiency-heat or excess-heat, all needs to consider the impact of damp-heat in the urinary bladder in prognosis of disease when treatment stranguria.The category that during prostatic hyperplasia belongs to, " essence is infirmity " is sick, patient mostly is gerontal patient, and suffering from a deficiency of the kidney is the Etiological pathogenesis that it is fallen ill.Exterior and interior relation between kidney and bladder, the prosperity and decline of kidney qi, directly affects gasification and the folding of bladder.With the passing of time stranguria does not heal, and thermal burn is cloudy, and wet impairment of YANG, easily causes and suffer from a deficiency of the kidney; Suffer from a deficiency of the kidney with the passing of time, damp and hot foul evil poison easily invades bladder, causes the recurrent exerbation of stranguria.Therefore, suffer from a deficiency of the kidney and to have great importance in the generation of stranguria, development and change of pathogenesis with damp-heat in the urinary bladder.The many old peoples of benign prostatic hyperplasia patients, taste virtual loss, the foundation of acquired constitution virtual loss causes the congenital foundation not enough.Therefore, suffer from a deficiency of the kidney and to have great importance in the generation of stranguria, development and change of pathogenesis with damp-heat in the urinary bladder, deficiency of spleen and stomach.BPH merge overactive bladder differentiation of tcm should from suffering from a deficiency of the kidney, stagnation of QI due to depression of the liver stays and damp-heat in the urinary bladder opinion is controlled, treatment when with invigorating the spleen and benefiting QI, enriching yin and nourishing kidney, eliminating damp-heat.
In Chinese medicine of the present invention money ginseng, Radix Fici beecheyanae merit with invigorating the spleen and benefiting QI, Rhizoma Pedicularis Davidii, musk orchid merit with enriching yin and nourishing kidney for monarch drug.Semen Abutili merit is with invigorating the spleen and replenishing QI; Folium Bauhiniae pernervosae merit is with the kidney invigorating astringency inducing; Fructus Akebiae, Folium Elaeagni delavayi merit take eliminating damp-heat as ministerial drug.Only leaf rock pearl merit is with nourishing YIN and clearing away heat; Caulis Aspidopterydis obcordatae merit is with clear sharp damp-heat in the urinary bladder.Adder's-fern merit is detoxified with clearing away heat-damp and promoting diuresis.Radix Glycyrrhizae uralensis merit is with heat-clearing and toxic substances removing, and inducing diuresis for treating stranguria syndrome is adjuvant.We's compatibility is reasonable, and all medicines share plays invigorating the spleen and benefiting QI, enriching yin and nourishing kidney, the effect of eliminating damp-heat altogether.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is further described, so that those skilled in the art more understands the present invention, but does not therefore limit the present invention.
Embodiment 1
Money ginseng 6g, Radix Fici beecheyanae 6g, Folium Bauhiniae pernervosae 6g, Semen Abutili 6g, Herba lathyri davidii 6g, thick leaf Radix Vladimiriae 6g, Rhizoma Pedicularis Davidii 6g, musk orchid 6g, Fructus Akebiae 6g, Folium Elaeagni delavayi 6g, solely leaf rock pearl 6g, Caulis Aspidopterydis obcordatae 6g, adder's-fern 6g, Radix Glycyrrhizae uralensis 6g.
Embodiment 2
Treat the Chinese medicine that BPH merges overactive bladder, each crude drug weight proportion is as follows:
Money ginseng 5g, Radix Fici beecheyanae 5g, Folium Bauhiniae pernervosae 5g, Semen Abutili 5g, Herba lathyri davidii 5g, thick leaf Radix Vladimiriae 5g, Rhizoma Pedicularis Davidii 5g, musk orchid 5g, Fructus Akebiae 5g, Folium Elaeagni delavayi 5g, solely leaf rock pearl 5g, Caulis Aspidopterydis obcordatae 5g, adder's-fern 5g, Radix Glycyrrhizae uralensis 5g.
Embodiment 3
Treat the Chinese medicine that BPH merges overactive bladder, each crude drug weight proportion is as follows:
Money ginseng 7g, Radix Fici beecheyanae 7g, Folium Bauhiniae pernervosae 7g, Semen Abutili 7g, Herba lathyri davidii 7g, thick leaf Radix Vladimiriae 7g, Rhizoma Pedicularis Davidii 7g, musk orchid 7g, Fructus Akebiae 7g, Folium Elaeagni delavayi 7g, solely leaf rock pearl 7g, Caulis Aspidopterydis obcordatae 7g, adder's-fern 7g, Radix Glycyrrhizae uralensis 7g.
Embodiment 4
Treat the Chinese medicine that BPH merges overactive bladder, each crude drug weight proportion is as follows:
Money ginseng 8g, Radix Fici beecheyanae 8g, Folium Bauhiniae pernervosae 8g, Semen Abutili 8g, Herba lathyri davidii 8g, thick leaf Radix Vladimiriae 8g, Rhizoma Pedicularis Davidii 8g, musk orchid 8g, Fructus Akebiae 8g, Folium Elaeagni delavayi 8g, solely leaf rock pearl 8g, Caulis Aspidopterydis obcordatae 8g, adder's-fern 8g, Radix Glycyrrhizae uralensis 8g.
Embodiment 5
Treat the Chinese medicine that BPH merges overactive bladder, each crude drug weight proportion is as follows:
Money ginseng 4g, Radix Fici beecheyanae 4g, Folium Bauhiniae pernervosae 4g, Semen Abutili 4g, Herba lathyri davidii 4g, thick leaf Radix Vladimiriae 4g, Rhizoma Pedicularis Davidii 4g, musk orchid 4g, Fructus Akebiae 4g, Folium Elaeagni delavayi 4g, solely leaf rock pearl 4g, Caulis Aspidopterydis obcordatae 4g, adder's-fern 4g, Radix Glycyrrhizae uralensis 4g.
Carried out clinical pharrnacokinetics test to Chinese medicine of the present invention, Details as Follows:
1 clinical data
1.1 physical data
BPH merges OAB patient 5O example, adopting computer random number method to be divided into can matched group, treatment group, and often organize 25 examples, the data such as two groups of ages, the course of disease, prostate volume, residual urine, PSA compare, no significant difference (P>0.05), in table 1.
1.2 selected exclusion standard 1. middle-aging males (50 ~ 85 years old); 2. the symptoms such as frequent micturition, urgent micturition, dysuria are had, international contest (IPSS) >=8 point; 3. B ultrasonic confirms that prostate increases, and prostate volume >30mL; 4. B ultrasonic confirms there is residual urine, and residual urine volume <100mL; 5. overactive bladder symptom score (OABSS) >=6 point.Exclusion standard: 1. prostate specific antigen (PSA) >4ng/mL; 2. previously the history of operation such as prostate, bladder is had; 3. suffer from bladder cancer, bladder or pelvic cavity and once had chemotherapy history person; 4. neurogenic bladder person; 5. urinary system infection person; 6. vesical calculus or urethral stricture person; 7. unconsciousness, can not know and express wish person.
2 Therapeutic Method
All patients stop using prostatic hyperplasia and overactive bladder medicine 2 weeks.I group gives doxazosin mesilate tablets (trade name: can how magnificent), 1 4mg, 1 time every night.Treatment group is take can on how magnificent basis, and add the Chinese medicine composition by the embodiment of the present invention 1, be decocted in water for oral dose, every day 1 dose, add water 1000ml, decocts and be condensed into 300-500ml, and points 2 times oral, each 1 time of morning and evening.Two groups of equal medications 3 months.
Observation index: when entering to organize and treatment 3 months after, adopt IPSS, OABSS, life quality scores (qualityoflife, QOL) evaluate patient situation respectively.
Statistical method: application SPSS17.0 software carries out statistical analysis, and measurement data all represents with (x ± s), and adopt paired t-test and two independent samples t test, P<0.05 is that difference has statistical significance.
3 therapeutic outcomes
This is organized in 50 examples and occurs slight dizzy 1 example, exits treatment, 1 example lost to follow-up, effective case 48 example of actual observation, treatment group and each 24 examples of matched group.
Before 3.1 liang of group treatment cross-reference PSS comparison therapy, two groups of contrast PSS compare, no significant difference (P>O.05); After treatment, comparatively the front two groups of contrast PSS differences for the treatment of have statistical significance (P<0.05); Compare between group after treatment, treatment group comparatively matched group obviously reduces (P<0.05).In table 1.
A table 1 liang group treatment cross-reference PSS compares (x ± s)
| Group | n | Before treatment | After treatment |
| Matched group | 24 | 20.23±2.74 | 12.81±4.26* |
| Treatment group | 24 | 19.55±2.65 | 9.52±3.31* △ |
Note: compared with before treatment, * P < O.05; Matched group compares,
△p < O.05.
Before and after 3.2 liang of group treatments, OABSS compares
Treat front two groups of OABSS to compare, no significant difference (P>0.05); Comparatively treat front two groups of OABSS differences after treatment and have statistical significance (P<0.05); Compare between group after treatment, treatment group comparatively matched group obviously reduces (P<0.05).In table 2.
Before and after table 2 liang group treatment, OABSS compares (x ± s) point
| Group | n | Before treatment | After treatment |
| Matched group | 24 | 12.03±0.87 | 8.36±0.64* |
| Treatment group | 24 | 11.94±0.83 | 5.78±0.88* △ |
Note: compared with before treatment, * P < O.05; Matched group compares,
△p < O.05.
Before and after 3.3 liang of group treatments, QOL compares
Treat front two groups of QOL to compare, no significant difference (P>0.05); Comparatively treat front two groups of QOL differences after treatment and have statistical significance (P<0.05); Compare between group after treatment, treatment group comparatively matched group obviously reduces (P<0.05).In table 3.
Before and after table 3 liang group treatment, QOL compares (x ± s) point
| Group | n | Before treatment | After treatment |
| Matched group | 24 | 4.53±0.51 | 3.92±1.23* |
| Treatment group | 24 | 4.72±0.46 | 2.67±0.72* △ |
Note: compared with before treatment, * P < O.05; Matched group compares,
△p < O.05.
Claims (3)
1. treat the Chinese medicine that BPH merges overactive bladder, be made up of the Chinese medicine of following weight portion:
Money ginseng 4-8 part, Radix Fici beecheyanae 4-8 part, Folium Bauhiniae pernervosae 4-8 part, Semen Abutili 4-8 part, Rhizoma Pedicularis Davidii 4-8 part, musk orchid 4-8 part, Fructus Akebiae 4-8 part, Folium Elaeagni delavayi 4-8 part, solely leaf rock pearl 4-8 part, Caulis Aspidopterydis obcordatae 4-8 part, adder's-fern 4-8 part, Radix Glycyrrhizae uralensis 4-8 part.
2. treatment BPH according to claim 2 merges the Chinese medicine of overactive bladder, it is characterized in that, is made up of the Chinese medicine of following weight portion:
Money ginseng 5-7 part, Radix Fici beecheyanae 5-7 part, Folium Bauhiniae pernervosae 5-7 part, Semen Abutili 5-7 part, Rhizoma Pedicularis Davidii 5-7 part, musk orchid 5-7 part, Fructus Akebiae 5-7 part, Folium Elaeagni delavayi 5-7 part, solely leaf rock pearl 5-7 part, Caulis Aspidopterydis obcordatae 5-7 part, adder's-fern 5-7 part, Radix Glycyrrhizae uralensis 5-7 part.
3. treatment BPH according to claim 2 merges the Chinese medicine of overactive bladder, it is characterized in that, is made up of the Chinese medicine of following weight portion:
Money join 6 parts, Radix Fici beecheyanae 6 parts, Folium Bauhiniae pernervosae 6 parts, Semen Abutili 6 parts, Rhizoma Pedicularis Davidii 6 parts, musk orchid 6 parts, Fructus Akebiae 6 parts, Folium Elaeagni delavayi 6 parts, solely 6 parts, leaf rock pearl, Caulis Aspidopterydis obcordatae 6 parts, adder's-fern 6 parts, Radix Glycyrrhizae uralensis 6 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510773736.7A CN105232990A (en) | 2015-11-13 | 2015-11-13 | Traditional Chinese medicine for treating BPH combined overactive bladder syndrome |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510773736.7A CN105232990A (en) | 2015-11-13 | 2015-11-13 | Traditional Chinese medicine for treating BPH combined overactive bladder syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105232990A true CN105232990A (en) | 2016-01-13 |
Family
ID=55030984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510773736.7A Pending CN105232990A (en) | 2015-11-13 | 2015-11-13 | Traditional Chinese medicine for treating BPH combined overactive bladder syndrome |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105232990A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101039688A (en) * | 2004-08-18 | 2007-09-19 | 生物健康解决方案股份有限公司 | Herbal composition for preventing or treating urinary incontinence and overactive bladder |
| CN103933020A (en) * | 2013-01-22 | 2014-07-23 | 复旦大学 | Application of curcumin in preparation of large-conductance calcium-activated potassium channel opener |
| CN104474390A (en) * | 2014-11-19 | 2015-04-01 | 王小龙 | Traditional Chinese medicine for treating overactive bladder and recurrent urethral infection |
| CN104758691A (en) * | 2015-04-13 | 2015-07-08 | 高永涛 | Traditional Chinese medicine for treating overactive bladder after prostate electrocision |
-
2015
- 2015-11-13 CN CN201510773736.7A patent/CN105232990A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101039688A (en) * | 2004-08-18 | 2007-09-19 | 生物健康解决方案股份有限公司 | Herbal composition for preventing or treating urinary incontinence and overactive bladder |
| CN103933020A (en) * | 2013-01-22 | 2014-07-23 | 复旦大学 | Application of curcumin in preparation of large-conductance calcium-activated potassium channel opener |
| CN104474390A (en) * | 2014-11-19 | 2015-04-01 | 王小龙 | Traditional Chinese medicine for treating overactive bladder and recurrent urethral infection |
| CN104758691A (en) * | 2015-04-13 | 2015-07-08 | 高永涛 | Traditional Chinese medicine for treating overactive bladder after prostate electrocision |
Non-Patent Citations (2)
| Title |
|---|
| 安文进等: "补肾活血方治疗BPH 合并膀胱过度活动症疗效观察", 《浙江中西医结合杂志》 * |
| 蔡光先等: "《中西医结合内科学》", 31 July 2006 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102416079A (en) | Chinese patent medicine for treating leucoderma | |
| CN102784363A (en) | Traditional Chinese medicine composition for treating pancreatic cancer and preparation method thereof | |
| CN102228603A (en) | Chinese medicine for treating retention of urine | |
| CN104206594A (en) | Herba Taxilli health-care tea capable of lowering blood pressure and blood lipid and preparation method thereof | |
| CN103719495B (en) | A kind of great burdock achene hypoglycemic health protection tea and preparation method thereof | |
| CN105169212A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN103181432B (en) | Kidney nourishing health care tea and preparation method thereof | |
| CN104043077A (en) | Traditional Chinese medicine composition for tonifying qi and nourishing blood | |
| CN101428114B (en) | Medicament for treating chronic hepatitis B, cirrhosis and liver ascites | |
| CN105596858A (en) | Traditional Chinese medicine composition for treating yin-deficiency night sweat and preparation method thereof | |
| CN105233188A (en) | Traditional Chinese medicine composition for treating liver cancer and application of traditional Chinese medicine composition | |
| CN105770075A (en) | Zhikening | |
| CN102600424B (en) | Chinese herba preparation for treating nephropyelitis and preparation method of Chinese herba preparation | |
| CN105311470A (en) | Application of pharmaceutical composition containing folium artemisiae argyi in preparing medicine for treating diabetic nephropathy | |
| CN104432386B (en) | Sangjisheng oral liquid for preventing soreness of waist and knees and weakness of muscles and bones and preparation method thereof | |
| CN103734425B (en) | A kind of leaves of Hawthorn hypoglycemic health protection tea and preparation method thereof | |
| CN102641424B (en) | Chinese prepared medicine mixture for treating acute urticaria | |
| CN105233078A (en) | Traditional Chinese medicine composition for treating viral hepatitis | |
| CN105106634A (en) | Traditional Chinese medicine preparation for treating acute appendicitis and application thereof | |
| CN105232990A (en) | Traditional Chinese medicine for treating BPH combined overactive bladder syndrome | |
| CN104740405B (en) | A kind of Chinese medicine preparation and preparation method for treating anaphylactoid purpura renal damage | |
| CN104436098A (en) | Traditional Chinese medicine preparation for treating multiple intestinal polyps | |
| CN104056113A (en) | Traditional Chinese medicine for treating acne vulgaris | |
| CN104825892B (en) | A kind of Chinese medicine preparation for treating ovulation bleeding and preparation method thereof | |
| CN108042744A (en) | A kind of Chinese medicine composition and preparation method for being used to treat prostatic disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160113 |
|
| RJ01 | Rejection of invention patent application after publication |